Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
23.64
-1.28 (-5.14%)
At close: Jul 6, 2026, 4:00 PM EDT
23.66
+0.02 (0.08%)
After-hours: Jul 6, 2026, 4:04 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $274.7 million as of July 6, 2026. Its market cap has increased by 224.06% in one year.
Market Cap
274.70M
Enterprise Value
174.57M
1-Year Change
224.06%
Ranking
Category
Stock Price
$23.64
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $274.70M, an increase of 127.68%. That is a compound annual growth rate of 16.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 274.70M | 30.38% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 309.42M |
| Eledon Pharmaceuticals | 305.34M |
| Bicycle Therapeutics | 303.68M |
| SAB Biotherapeutics | 299.74M |
| MacroGenics | 299.38M |
| Galectin Therapeutics | 297.01M |
| Adagene | 295.34M |
| Conexeu Sciences | 290.60M |